Skip to main content
OpenTrials

Clinical trial condition

Chemotherapy-Induced Thrombocytopenia

Explore clinical trials studying Chemotherapy-Induced Thrombocytopenia. Study availability and eligibility vary by location and protocol.

19 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Chemotherapy-Induced Thrombocytopenia trial results

Completed

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

NCT03471078

Conditions
Blood Platelet Disorders, Chemotherapy-Induced Thrombocytopenia, Cytopenia, +3 more
Locations
  • Dova Site Anaheim, California, United States
  • Dova Site Bakersfield, California, United States
  • Dova Site Riverside, California, United States
  • Dova Site Santa Monica, California, United States
View all 55 locations
View Trial Details
Completed

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

NCT01663441

Conditions
Blood Platelet Disorders, Chemotherapy-Induced Thrombocytopenia, Cytopenia, +3 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The Third Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
  • The First Hospital of Jilin University Changchun, Jilin, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

NCT00413283

Conditions
Blood Platelet Disorders, Bronchial Neoplasms, Cancer, +18 more
Locations
  • Research Site Glendale, Arizona, United States
  • Research Site Glendale, Arizona, United States
  • Research Site Anaheim, California, United States
  • Research Site Anaheim, California, United States
View all 113 locations
View Trial Details

Related conditions